Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.130
-0.030 (-2.59%)
Apr 25, 2025, 12:18 PM EDT - Market open
Cytosorbents Employees
Cytosorbents had 149 employees as of December 31, 2024. The number of employees decreased by 37 or -19.89% compared to the previous year.
Employees
149
Change (1Y)
-37
Growth (1Y)
-19.89%
Revenue / Employee
$238,889
Profits / Employee
-$139,053
Market Cap
70.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
CTSO News
- 4 days ago - CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program - PRNewsWire
- 8 days ago - CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller - PRNewsWire
- 11 days ago - CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America - PRNewsWire
- 21 days ago - CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants - PRNewsWire
- 24 days ago - Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - PRNewsWire
- 5 weeks ago - CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit - PRNewsWire
- 7 weeks ago - CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller - GlobeNewsWire